Physiomics Share News (PYC)

IN BRIEF: Physiomics wins further contract from Bicycle Therapeutics

Physiomics PLC - London-based oncology consultancy, which uses mathematical models to support the development of cancer treatment regimens and personalised medicine solutions - Gets a further contract from existing client Bicycle Therapeutics relating to an undisclosed programme. Expects this to be completed in Physiomics's current financial year.

Physiomics wins further contract with Bicycle Therapeutics

(Sharecast News) - Oncology consultancy Physiomics revealed on Friday that it had been awarded a further contract by existing client Bicycle Therapeutics.

Physiomics confident despite weaker first half

(Sharecast News) - Oncology consultancy firm Physiomics reported revenue of £0.34m in its first half on Tuesday - a slight decrease from the £0.37m reported in the same period a year earlier.

EARNINGS SUMMARY: Foxtons profit doubles; Reach yearly profit dips

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Physiomics COO Chassagnole changes title to chief scientific officer

(Alliance News) - Physiomics PLC on Friday said Christophe Chassagnole's job title has changed from chief operating officer to chief scientific officer.

Physiomics announces another contract with client Cancer Research UK

(Alliance News) - Physiomics PLC on Wednesday said it entered into a further contract with its existing client Cancer Research UK to conduct analyses of a blood cancer treatment.

AIM WINNERS & LOSERS: musicMagpie flies; video game shares fall

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Physiomics shares jump on dosing tool study findings

(Alliance News) - Physiomics PLC on Monday hailed new opportunities in the emerging personalised dosing space, following the completion of its Partner study.

UK shareholder meetings calendar - next 7 days

IN BRIEF: Physiomics shares rise on Ankyra contract extension

Physiomics PLC - Oncology consultancy based in Oxford, England - Says it has been awarded a further contract by existing client Ankyra Therapeutics. The contract builds on work announced in March, and is expected to complete in the first quarter of 2023.

AIM WINNERS & LOSERS: Manolete swings to loss amid case troubles

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Physiomics inks deal to work with Cancer Research UK

(Sharecast News) - Modelling and simulation-focussed consultancy Physiomics that it has signed an agreement to work with Cancer Research UK, it announced on Wednesday.

AIM WINNERS & LOSERS: Physiomics wins deal; DeepVerge eyes cash raise

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Physiomics surges on contract win with Cancer Research UK

(Alliance News) - Physiomics PLC shares jumped on Wednesday after it signed an agreement to work with Cancer Research UK.

IN BRIEF: Physiomics wins third contract from Numab Therapeutics

Physiomics PLC - oncology consultancy based in Oxford, England - Wins third contract by an existing client, Numab Therapeutics. Says it will use its PKPD modelling capabilities to support the translation of pre-clinical to clinical data with a focus on dose selection. The project is expected to be completed between now and the end of 2022.